EE568 Does the Introduction of an Infliximab Biosimilar Always Result in Savings for Hospitals? A Descriptive Study Using Real-World Data
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.833
https://www.valueinhealthjournal.com/article/S1098-3015(23)03963-3/fulltext
Title :
EE568 Does the Introduction of an Infliximab Biosimilar Always Result in Savings for Hospitals? A Descriptive Study Using Real-World Data
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03963-3&doi=10.1016/j.jval.2023.09.833
First page :
Section Title :
Open access? :
No
Section Order :
10323